Detalhe da pesquisa
1.
Genomic imbalances analysis provides new insight into prognostic factors in adult and pediatric T-ALL.
Blood
; 2024 Mar 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38518104
2.
IL-7 receptor expression is frequent in T-cell acute lymphoblastic leukemia and predicts sensitivity to JAK inhibition.
Blood
; 142(2): 158-171, 2023 07 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37023368
3.
Harnessing the MYB-dependent TAL1 5'super-enhancer for targeted therapy in T-ALL.
Mol Cancer
; 22(1): 12, 2023 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36650499
4.
PRC2 loss of function confers a targetable vulnerability to BET proteins in T-ALL.
Blood
; 138(19): 1855-1869, 2021 11 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34125178
5.
Prognostic value and oncogenic landscape of TP53 alterations in adult and pediatric T-ALL.
Blood
; 141(11): 1353-1358, 2023 03 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36599110
6.
Integrated omics approaches to predict T-LBL relapse risk.
Blood
; 137(17): 2280-2282, 2021 04 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-33914078
7.
The oncogenetic landscape and clinical impact of BCL11B alterations in adult and pediatric T-cell acute lymphoblastic leukemia.
Haematologica
; 108(11): 3165-3169, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36891734
8.
Comprehensive genetic profiling reveals frequent alterations of driver genes on the X chromosome in extranodal NK/T-cell lymphoma.
Cancer Res
; 2024 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38657099
9.
From a drug repositioning to a structure-based drug design approach to tackle acute lymphoblastic leukemia.
Nat Commun
; 14(1): 3079, 2023 05 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37248212
10.
Multimodal cartography of human lymphopoiesis reveals B and T/NK/ILC lineages are subjected to differential regulation.
iScience
; 26(10): 107890, 2023 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37766969
11.
Adenylate kinase 2 expression and addiction in T-ALL.
Blood Adv
; 5(3): 700-710, 2021 02 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33560378
12.
Epigenetic analysis of patients with T-ALL identifies poor outcomes and a hypomethylating agent-responsive subgroup.
Sci Transl Med
; 13(595)2021 05 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34039737
13.
Oncogenetic landscape and clinical impact of IDH1 and IDH2 mutations in T-ALL.
J Hematol Oncol
; 14(1): 74, 2021 05 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33941203
14.
Blueprint of human thymopoiesis reveals molecular mechanisms of stage-specific TCR enhancer activation.
J Exp Med
; 217(9)2020 09 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32667968
15.
BRD4 Regulates Metastatic Potential of Castration-Resistant Prostate Cancer through AHNAK.
Mol Cancer Res
; 17(8): 1627-1638, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31110158
16.
BET protein targeting suppresses the PD-1/PD-L1 pathway in triple-negative breast cancer and elicits anti-tumor immune response.
Cancer Lett
; 465: 45-58, 2019 11 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-31473251
17.
BET Proteins Exhibit Transcriptional and Functional Opposition in the Epithelial-to-Mesenchymal Transition.
Mol Cancer Res
; 16(4): 580-586, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29437854
18.
BET proteins in abnormal metabolism, inflammation, and the breast cancer microenvironment.
J Leukoc Biol
; 104(2): 265-274, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29493812
19.
Impact of T-cell Receptor Status on Mutational Landscape and Outcome in T-ALL.
Hemasphere
; 7(4): e871, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36950021